|Articles|September 1, 2020
COVID-19: A Catalyst for Technological Change in Clinical Research
Author(s)Elligo
Decentralized or hybrid trial models have not been widely adopted in clinical research until now. See how COVID-19 is ushering in a new era of clinical research.
Trending on Applied Clinical Trials Online
1
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
2
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
3
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
4
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
5